Search results for "Colorectal cancer"
Azithromycin gets warning, incretin mimetics investigated
This regulatory update covers a new warning on azithromycin about abnormal changes in the electrical activity of the heart, and a possible increased risk of pancreatitis and precancerous findings from incretin mimetic drugs.
https://immattersacp.org/archives/2013/05/fda.htm
1 May 2013
Patients and priorities in prostate cancer care
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
https://immattersacp.org/archives/2017/11/patients-and-priorities-in-prostate-cancer-care.htm
1 Nov 2017
Overcoming colonoscopy's image problem
Colon cancer screening saves lives, but internists have to overcome patients' initial unease with the test. They also need to sort through the multiple guidelines released in 2008 and help their patients choose among the many screening regimens.
https://immattersacp.org/archives/2009/01/colon.htm
1 Jan 2009
The Colonoscopy Conundrum
Studies suggest the importance of screening, but convincing patients is another matter.
https://immattersacp.org/archives/2008/01/colon.htm
1 Jan 2008
Task Force recommends aspirin for primary prevention of CVD, colorectal cancer
The Task Force recommended that low-dose aspirin be initiated for the primary prevention of CVD and colorectal cancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.
https://immattersacp.org/weekly/archives/2016/04/12/1.htm
12 Apr 2016
Uptake of CRC screening leaves room for improvement
This issue also covers IMGs and immigration policy, along with conference coverage on gastroenterology and the art of diagnosis.
https://immattersacp.org/archives/2019/01/uptake-of-crc-screening-leaves-room-for-improvement.htm
1 Jan 2019
European trial finds reduction in cancers but not deaths with invitation to colonoscopy screening
Healthy patients in Poland, Norway, and Sweden were randomized to usual care or an invitation to screening colonoscopy; only 42% of invited patients responded. The invited group had an 18% lower risk of colorectal cancer at 10 years compared to the usual care group.
https://immattersacp.org/weekly/archives/2022/10/18/4.htm
18 Oct 2022
Jury is out on truth in clinical trials
A digest of this month's issue, including the risks and drawbacks of stopping clinical trials early for benefit, colon cancer screening and an update on an early adopter of patient communication portals.
https://immattersacp.org/archives/2009/01/editor.htm
1 Jan 2009
Colonoscopies often recommended to patients with limited life expectancy
A study of patients ages 65 years and older found that 58.1% of those with life expectancy of less than five years and no polyps or only small hyperplastic polyps were told to return for future surveillance, as were 74.8% of those with life expectancy of five to 10 years.
https://immattersacp.org/weekly/archives/2023/03/21/4.htm
21 Mar 2023
‘Preventive’ measures don't translate properly to the public
Prevention is an important tool, but it must be placed in the context of evidence and value. The cost of ignoring that is false reassurance and the politicization of medical care.
https://immattersacp.org/archives/2010/03/presidents.htm
1 Mar 2010